Shareholder Alert: Tripp Levy PLLC Represents ISTA Pharmaceuticals Shareholders in Connection with the acquisition of the company by Bausch & Lomb
NEW YORK, March 26, 2012 /PRNewswire/ -- Tripp Levy PLLC, a leading national securities law firm, notifies investors of ISTA Pharmaceuticals of potential claims of breaches of fiduciary duty and other violations of state law against the board of directors of ISTA in connection with the potential sale of the company to Bausch & Lomb. It was announced that Bausch will acquire all the outstanding shares of ISTA for only $9.10 per share in cash.
The investigation concerns whether the ISTA Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the company and whether Bausch is underpaying for ISTA’s shares, thus unlawfully harming stockholders. Indeed, analysts have projected that the true going forward value of ISTA is worth at least $12 per share,
If you own ISTA common stock and you wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact Tripp Levy Tripp Levy PLLC 125 East 82nd Street 9th Floor New York, New York Toll Free: 877-772-3975 Email: firstname.lastname@example.org Tripp Levy PLLC is a national law firm that specializes in mergers & acquisitions, takeover litigation, shareholder rights, and corporate governance matters in state and federal courts throughout the United States. Attorney advertising. Prior results do not guarantee a similar outcome. SOURCE Tripp Levy PLLC Rating :